Barr Elizabeth Lm, Maple-Brown Louise J, Barzi Federica, Hughes Jaquelyne T, Jerums George, Ekinci Elif I, Ellis Andrew G, Jones Graham Rd, Lawton Paul D, Sajiv Cherian, Majoni Sandawana W, Brown Alex Dh, Hoy Wendy E, O'Dea Kerin, Cass Alan, MacIsaac Richard J
Menzies School of Health Research, Darwin, Australia; Baker IDI Heart and Diabetes Institute, Melbourne, Australia.
Menzies School of Health Research, Darwin, Australia; Division of Medicine, Royal Darwin Hospital, Australia.
Clin Biochem. 2017 Apr;50(6):301-308. doi: 10.1016/j.clinbiochem.2016.11.024. Epub 2016 Nov 25.
The Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation that combines creatinine and cystatin C is superior to equations that include either measure alone in estimating glomerular filtration rate (GFR). However, whether cystatin C can provide any additional benefits in estimating GFR for Indigenous Australians, a population at high risk of end-stage kidney disease (ESKD) is unknown.
Using a cross-sectional analysis from the eGFR Study of 654 Indigenous Australians at high risk of ESKD, eGFR was calculated using the CKD-EPI equations for serum creatinine (eGFRcr), cystatin C (eGFRcysC) and combined creatinine and cystatin C (eGFRcysC+cr). Reference GFR (mGFR) was determined using a non-isotopic iohexol plasma disappearance technique over 4h. Performance of each equation to mGFR was assessed by calculating bias, % bias, precision and accuracy for the total population, and according to age, sex, kidney disease, diabetes, obesity and c-reactive protein.
Data were available for 542 participants (38% men, mean [sd] age 45 [14] years). Bias was significantly greater for eGFRcysC (15.0mL/min/1.73m; 95% CI 13.3-16.4, p<0.001) and eGFRcysC+cr (10.3; 8.8-11.5, p<0.001) compared to eGFRcr (5.4; 3.0-7.2). Accuracy was lower for eGFRcysC (80.3%; 76.7-83.5, p<0.001) but not for eGFRcysC+cr (91.9; 89.3-94.0, p=0.29) compared to eGFRcr (90.0; 87.2-92.4). Precision was comparable for all equations. The performance of eGFRcysC deteriorated across increasing levels of c-reactive protein.
Cystatin C based eGFR equations may not perform well in populations with high levels of chronic inflammation. CKD-EPI eGFR based on serum creatinine remains the preferred equation in Indigenous Australians.
结合肌酐和胱抑素C的慢性肾脏病流行病学协作组(CKD-EPI)方程在估算肾小球滤过率(GFR)方面优于仅包含其中一项指标的方程。然而,对于澳大利亚原住民这一终末期肾病(ESKD)高危人群,胱抑素C在估算GFR时是否能带来额外益处尚不清楚。
采用来自ESKD高危的654名澳大利亚原住民的eGFR研究的横断面分析,使用CKD-EPI方程分别计算血清肌酐的eGFR(eGFRcr)、胱抑素C的eGFR(eGFRcysC)以及肌酐和胱抑素C联合的eGFR(eGFRcysC+cr)。通过4小时非同位素碘海醇血浆清除技术测定参考GFR(mGFR)。通过计算总体人群以及根据年龄、性别、肾病、糖尿病、肥胖和C反应蛋白的偏差、%偏差、精密度和准确性,评估每个方程对mGFR的性能。
542名参与者(38%为男性,平均[标准差]年龄45[14]岁)的数据可用。与eGFRcr(5.4;3.0 - 7.2)相比,eGFRcysC(15.0mL/min/1.73m²;95%CI 13.3 - 16.4,p<0.001)和eGFRcysC+cr(10.3;8.8 - 11.5,p<0.001)的偏差显著更大。与eGFRcr(90.0;87.2 - 92.4)相比,eGFRcysC的准确性较低(80.3%;76.7 - 83.5,p<0.001),但eGFRcysC+cr的准确性无差异(91.9;89.3 - 94.0,p = 0.29)。所有方程的精密度相当。随着C反应蛋白水平升高,eGFRcysC的性能变差。
基于胱抑素C的eGFR方程在慢性炎症水平较高的人群中可能表现不佳。基于血清肌酐的CKD-EPI eGFR仍是澳大利亚原住民的首选方程。